Central cyclooxygenase inhibitors reduced IL-1β-induced hyperalgesia in temporomandibular joint of freely moving rats
Authors:
- Dong K. AhnDong K. Ahn
- Jong M. ChaeJCJong M. Chae
- Hyo S. ParkHPHyo S. Park
- 1 September 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 117 (1) , 204-213
Abstract
Microinjection of formalin (5%, 50 microl) into a temporomandibular joint (TMJ) causes noxious behavioral responses in freely moving rats. In the present study, we investigated the role of central cyclooxygenase (COX) pathways in IL-1beta-induced hyperalgesia with formalin-induced TMJ pain model. Intra-articular injection of 100 pg or 1 ng of IL-1beta significantly facilitated formalin-induced behavior by 130 or 174% in the number of scratches. Intracisternal administration of 100 pg or 1 ng of IL-1beta also significantly increased formalin-induced behavior by 166 or 82% in the number of scratches. IL-1beta-induced hyperalgesia was blocked by pretreatment with IL-1 receptor antagonist. Intracisternal pretreatment with SC-560, a selective COX-1 inhibitor, or NS-398, a selective COX-2 inhibitor, abolished intra-articular administration of IL-1beta-induced hyperalgesic response. Intracisternal pretreatment with NS-398, a selective COX-2 inhibitor, abolished the intracisternal administration of IL-1beta-induced hyperalgesic response, while pretreatment with SC-560, a selective COX-1 inhibitor, did not change IL-1beta-induced hyperalgesic responses. On the other hand, pretreatment with acetaminophen, a tentative COX-3 inhibitor, also abolished both intra-articular and intracisternal administration of IL-1beta-induced hyperalgesic responses. These results indicate that central COX-2 plays important role in the central administration of IL-1beta-induced hyperalgesia and that central COX-1/2 pathways mediate peripheral administration of IL-1beta-induced hyperalgesia in the TMJ. Central COX-3 inhibitor seems to play an important role in the nociceptive process associated with both peripheral and central administration of IL-1beta-induced hyperalgesia in TMJ. It is concluded that central acting of COX-3 inhibitors may be of therapeutic value in the treatment of inflammatory pain in TMJ.Keywords
This publication has 57 references indexed in Scilit:
- Peripheral glutamate receptors participate in interleukin-1β-induced mechanical allodynia in the orofacial area of ratsNeuroscience Letters, 2004
- Differential responses of intracisternal injection of interleukin-1 ? to acute and inflammatory orofacial pain model in freely moving ratsNeuroscience Research Communications, 2002
- Influence of sex on reflex jaw muscle activity evoked from the rat temporomandibular jointBrain Research, 2002
- COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expressionProceedings of the National Academy of Sciences, 2002
- Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?Clinical Infectious Diseases, 2000
- Evidence That Excitatory Amino Acid Receptors within the Temporomandibular Joint Region Are Involved in the Reflex Activation of the Jaw MusclesJournal of Neuroscience, 1998
- Interleukin-1β in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility, and anterior open biteJournal of Oral and Maxillofacial Surgery, 1998
- Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving ratsNeuroscience Letters, 1998
- Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisArthritis & Rheumatism, 1990
- The stress of a novel environment reduces formalin pain: Possible role of serotoninEuropean Journal of Pharmacology, 1986